-+ 0.00%
-+ 0.00%
-+ 0.00%

Neuphoria Therapeutics Inc. Granted 180-Day Extension by Nasdaq to Regain Compliance with Listing Rule

Reuters·09/16/2025 13:03:57

Please log in to view news